Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Proceedings from the National Cancer Institute's second international workshop on the biology, prevention, and treatment of relapse after hematopoietic stem cell tansplantation: Part III. Prevention and treatment of relapse after allogeneic transplantation
    Journal Article

    de Lima, M.; Porter, D. L.; Battiwalla, M.; Bishop, M. R.; Giralt, S. A.; Hardy, N. M.; Kröger, N.; Wayne, A. S.; Schmid, C.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant
    Meeting Abstract

    Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
    Blood (2013)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Observational study of quality of life and symptomatic response in myelofibrosis patients receiving undergoing treatment with conventional therapy, the measures trial and allogeneic stem cell transplant, the symptoms trial
    Meeting Abstract

    Fauble, V.; Emanuel, R. M.; Geyer, H. L.; Dueck, A. C.; Kroeger, N.; Scott, B. L.; Gerds, A. T.; Popat, U. R.; Giralt, S. A.; Gupta, V.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)
    Meeting Abstract

    Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Higher stem cell dose infusion as rescue after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis
    Meeting Abstract

    Shah, N.; Williams, L. A.; Worthing, A.; Shi, Q.; Wang, X. S.; Johnson, V.; Mendoza, T. R.; Qazilbash, M. H.; Champlin, R. E.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save